Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 25, 2021
Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort studyYi Hu, Xubin Zheng, Lina Davies Forsman, et al.Journal of Clinical Microbiology|September 27, 2013
Rifampin heteroresistance in Mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methodsDorte Bek Folkvardsen, Vibeke Ø Thomsen, Leen Rigouts, et al.Antimicrobial Agents and Chemotherapy|February 1, 2012
Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesisThulasi Warrier, Marielle Tropis, Jim Werngren, et al.Microbiology Spectrum|September 22, 2023
In vitro activity of new combinations of β-lactam and β-lactamase inhibitors against the Mycobacterium tuberculosis complexElin Economou Lundeberg, Viktoria Andersson, Maria Wijkander, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 17, 2020
Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosisThomas Schön, Jim Werngren, Diana Machado, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 5, 2020
Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates - the EUCAST broth microdilution reference method for MIC determinationThomas Schön, Jim Werngren, Diana Machado, et al.Antimicrobial Agents and Chemotherapy|December 1, 2023
Loss-of-function mutations in ndh do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in Mycobacterium tuberculosisSushil Pandey, Catherine Vilchèze, Jim Werngren, et al.The Journal of Antimicrobial Chemotherapy|March 12, 2011
Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosisAnandi Martin, Fabienne Paasch, Sven Docx, et al.The Journal of Antimicrobial Chemotherapy|August 21, 2018
Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic settingKatarina Niward, Lina Davies Forsman, Judith Bruchfeld, et al.Mbio|October 23, 2014
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter studyPaolo Miotto, Andrea M Cabibbe, Silke Feuerriegel, et al.Pageof 6